Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;23(9):2296-300.
doi: 10.1016/j.jstrokecerebrovasdis.2014.04.018. Epub 2014 Aug 23.

Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature

Brian E Tark  1 , Steven R Messe  2 , Clotilde Balucani  1 , Steven R Levine  3
Affiliations
Review

Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature

Brian E Tark et al. J Stroke Cerebrovasc Dis. 2014 Oct.

Abstract

Background: Prior reports have linked both ischemic and hemorrhagic stroke to use of sympathomimetic drugs including phenylephrine. The purpose of this study is to describe the first case, to our knowledge of intracerebral hemorrhage (ICH) after oral use of phenylephrine and to systematically review the literature on phenylephrine and acute stroke.

Methods: A case report and review of the literature.

Results: A 59-year-old female presented with thunderclap headache, right hemiparesis, aphasia, and left gaze deviation. Head computed tomography (CT) showed a left frontal ICH with intraventricular and subarachnoid extension. She had no significant past medical history. For the previous 30 days, the patient was taking multiple common cold remedies containing phenylephrine to treat sinusitis. CT and magnetic resonance angiography showed no causative vascular abnormality. Catheter cerebral angiography supported reversible cerebral vasoconstriction syndrome (RCVS). Phenylephrine was determined to be the most likely etiology for her hemorrhage. A review of the literature, found 7 cases describing phenylephrine use with acute stroke occurrence: female, 5 of 7 (71%); route of administration, nasal (n = 3), ophthalmic (n = 2), intravenous (n = 1), intracorporeal injection (n = 1). Stroke types were subarachnoid hemorrhage (n = 5), ICH (n = 4), and ischemic (n = 1). One case reported RCVS after phenylephrine use.

Conclusions: It is scientifically plausible that phenylephrine may cause strokes, consistent with the pharmacologic properties and adverse event profiles of similar amphetamine-like sympathomimetics. As RCVS has been well described in association with over-the-counter sympathomimetics, a likely, although not definitive, causal relationship between phenylephrine and ICH is proposed.

Keywords: Hemorrhagic stroke; phenylephrine; reversible cerebral vasoconstriction syndrome; sympathomimetics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Head CT displaying fronto-parietal ICH with intraventricular involvement.
Figure 2
Figure 2
Lateral view cerebral angiogram showing diffuse segmental vasoconstriction.
Figure 3
Figure 3
See this image and copyright information in PMC

References

    1. Cantu C, Arrauz A, Murillo-Bonilla LM, Lopez M, Barinagarrementeria F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003;34:1667–1673. - PubMed
    1. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833–1838. - PubMed
    1. Dollery C. Therapeutic Drugs. Edinburgh: Churchill Livingstone; 1999. p. 2.
    1. Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongestant. An illogical way to control methamphetamine abuse. British Journal of Clinical Pharmacology. 2007;63:10–14. - PMC - PubMed
    1. Johnson DA, Hricik JG. The pharmacology of α-adrenergic decongestants. Pharmacotherapy. 1993;13:110S–115S. - PubMed

MeSH terms